Insider Shareholders with Direct Ownership of Vyant Bio, Inc. (VYNT)
This section provides a comprehensive overview of the insiders with direct ownership of Vyant Bio, Inc. (VYNT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Vyant Bio, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
John Pappajohn
Director |
3,517,972 | 0 | 4,781,204 $0 | 36 |
Jan 31, 2019
Added 17.3%
|
|
Paul R. Hansen
Director |
685,331 | 0 | 152,995 $0 | 9 |
Jan 17, 2023
Added 2.57%
|
|
Panna Sharma
Chief Executive Officer |
152,500 | 0 | 152,500 $0 | 5 |
Mar 17, 2016
Added 0.33%
|
|
Michael Glenn Miles
Chief Financial Officer |
150,000 | 0 | 150,000 $0 | 1 |
Jan 31, 2019
Added 50.0%
|
|
Raju S.K. Chaganti
Director |
10,000 | 83,333 | 144,071 $0 | 10 |
Sep 28, 2017
Added 1.71%
|
|
Edmund Cannon
Director |
55,979 | 0 | 61,873 $0 | 5 |
Jan 31, 2019
Added 41.27%
|
|
Marcus Boehm
Director |
155,413 | 0 | 56,484 $0 | 5 |
Apr 18, 2022
Added 11.42%
|
|
Yung Ping Yeh
Director |
1,374,580 | 0 | 56,240 $0 | 5 |
Mar 30, 2022
Added 43.6%
|
|
Howard Mc Leod
Director |
56,978 | 0 | 43,927 $0 | 6 |
Mar 30, 2022
Added 49.74%
|
|
John A Roberts
Chief Executive Officer |
327,523 | 0 | 39,807 $0 | 7 |
Nov 24, 2021
Added 11.16%
|
|
Andrew D.C. La Frence
Chief Financial Officer |
37,336 | 0 | 34,336 $0 | 3 |
Nov 23, 2021
Added 12.71%
|
|
R John Fletcher
Director |
102,017 | 0 | 23,895 $0 | 7 |
Jan 17, 2023
Added 15.45%
|
|
Joanna Horobin
Director |
85,520 | 0 | 23,123 $0 | 6 |
Jan 17, 2023
Added 24.56%
|
|
Geoffrey E. Harris
Director |
202,884 | 765 | 19,761 $0 | 15 |
Jan 17, 2023
Added 22.42%
|
|
Edward J Sitar
Chief Financial Officer |
17,500 | 3,333 | 14,167 $0 | 6 |
Nov 16, 2016
Reduced 19.05%
|
|
Michael J. Welsh
Director |
7,540 | 0 | 12,540 $0 | 4 |
Sep 28, 2017
Added 16.62%
|
|
Franklyn G Prendergast
Director |
12,500 | 0 | 12,500 $0 | 4 |
Sep 28, 2017
Added 16.67%
|
|
Paul Rothman
Director |
5,000 | 0 | 5,000 $0 | 1 |
May 22, 2014
Added 50.0%
|
|
Keith L Brownlie
Director |
5,000 | 0 | 5,000 $0 | 1 |
May 22, 2014
Added 50.0%
|
|
Rita Shaknovich
Chief Medical Officer |
3,000 | 0 | 3,000 $0 | 1 |
Jul 08, 2015
Added 50.0%
|
|
Steven Hepburn
VP of Biopharma Marketing |
3,000 | 0 | 3,000 $0 | 1 |
May 29, 2015
Added 50.0%
|
|
Tommy G Thompson
Director |
2,500 | 0 | 2,500 $0 | 1 |
Oct 10, 2013
Added 50.0%
|
|
Robert Thomas Fremeau Jr.
Chief Scientific Officer |
1,000 | 0 | 1,000 $0 | 1 |
Oct 28, 2021
Added 50.0%
|
|
Igor Gitelman
Chief Accounting Officer |
1,874 | 937 | 937 $0 | 3 |
May 25, 2017
Added 50.0%
|